Related Experiment Video
Updated: Mar 30, 2026
12:20
Fabrication of Carbon Nanotube High-Frequency Nanoelectronic Biosensor for Sensing in High Ionic Strength Solutions
Published on: July 22, 2013
18.8K
Carbon nanotube biosensors
Carmen-Mihaela Tîlmaciu1, May C Morris1
1Cell Cycle Biosensors and Inhibitors, Faculté de Pharmacie, Institut des Biomolécules Max Mousseron, Centre National de la Recherche Scientifique-UMR 5247 Montpellier, France.
Frontiers in Chemistry
|November 19, 2015
Summary
Carbon nanotubes (CNTs) offer unique properties for biosensing, enabling the detection of disease biomarkers. This review covers CNTs
Area of Science:
- Materials Science
- Biotechnology
- Nanotechnology
Background:
- Nanomaterials exhibit unique properties suitable for biosensing.
- Carbon nanotubes (CNTs) are excellent scaffolds for biomolecule immobilization.
- CNTs possess exceptional physical, chemical, electrical, and optical characteristics for signal transduction.
Purpose of the Study:
- To provide a comprehensive review of carbon nanotubes (CNTs) for biosensing applications.
- To describe the properties, functionalization, cellular uptake, biocompatibility, and toxicity of CNTs.
- To review the historical development of biosensors, focusing on CNT-conjugates for biomarker detection, especially cancer biomarkers.
Main Methods:
- Literature review of carbon nanotubes and biosensor development.
- Analysis of CNT properties and their application in biosensing.
- Focus on CNT-conjugates for specific biomarker detection.
Main Results:
- CNTs are highly suitable for biosensing due to their unique characteristics.
- Functionalized CNTs can be used to detect various analytes, metabolites, and disease biomarkers.
- Specific focus on CNT-conjugates for cancer biomarker detection is highlighted.
Conclusions:
- Carbon nanotubes represent a promising platform for advanced biosensing technologies.
- Further research into CNTs' biocompatibility and toxicity is essential for clinical translation.
- CNT-based biosensors offer potential for early disease diagnosis and monitoring.
